Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1997 Oct-Dec;3(4):443–452. doi: 10.3201/eid0304.970405

Chronic sequelae of foodborne disease.

J A Lindsay 1
PMCID: PMC2640087  PMID: 9366595

Abstract

In the past decade the complexity of foodborne pathogens, as well as their adaptability and ability to cause acute illness, and in some cases chronic (secondary) complications, have been newly appreciated. This overview examines long-term consequences of foodborne infections and intoxications to emphasize the need for more research and education.

Full Text

The Full Text of this article is available as a PDF (47.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. E., Maizels R. M. Immunology of human helminth infection. Int Arch Allergy Immunol. 1996 Jan;109(1):3–10. doi: 10.1159/000237225. [DOI] [PubMed] [Google Scholar]
  2. Archer D. L., Young F. E. Contemporary issues: diseases with a food vector. Clin Microbiol Rev. 1988 Oct;1(4):377–398. doi: 10.1128/cmr.1.4.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Behar S. M., Porcelli S. A. Mechanisms of autoimmune disease induction. The role of the immune response to microbial pathogens. Arthritis Rheum. 1995 Apr;38(4):458–476. doi: 10.1002/art.1780380403. [DOI] [PubMed] [Google Scholar]
  4. Bolton C. F. The changing concepts of Guillain-Barré syndrome. N Engl J Med. 1995 Nov 23;333(21):1415–1417. doi: 10.1056/NEJM199511233332110. [DOI] [PubMed] [Google Scholar]
  5. Bruckner D. A. Amebiasis. Clin Microbiol Rev. 1992 Oct;5(4):356–369. doi: 10.1128/cmr.5.4.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bunning V. K., Lindsay J. A., Archer D. L. Chronic health effects of microbial foodborne disease. World Health Stat Q. 1997;50(1-2):51–56. [PubMed] [Google Scholar]
  7. Chappell C. L., Matson C. C. Giardia antigen detection in patients with chronic gastrointestinal disturbances. J Fam Pract. 1992 Jul;35(1):49–53. [PubMed] [Google Scholar]
  8. Chiodini R. J. Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbiol Rev. 1989 Jan;2(1):90–117. doi: 10.1128/cmr.2.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Conrad B., Weidmann E., Trucco G., Rudert W. A., Behboo R., Ricordi C., Rodriquez-Rilo H., Finegold D., Trucco M. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature. 1994 Sep 22;371(6495):351–355. doi: 10.1038/371351a0. [DOI] [PubMed] [Google Scholar]
  10. Coulombe R. A., Jr Biological action of mycotoxins. J Dairy Sci. 1993 Mar;76(3):880–891. doi: 10.3168/jds.S0022-0302(93)77414-7. [DOI] [PubMed] [Google Scholar]
  11. Creppy E. E., Baudrimont I., Betbeder A. M. Prevention of nephrotoxicity of ochratoxin A, a food contaminant. Toxicol Lett. 1995 Dec;82-83:869–877. doi: 10.1016/0378-4274(95)03601-6. [DOI] [PubMed] [Google Scholar]
  12. Derouin F. Pathogeny and immunological control of toxoplasmosis. Braz J Med Biol Res. 1992;25(12):1163–1169. [PubMed] [Google Scholar]
  13. Farr S. B., Kogoma T. Oxidative stress responses in Escherichia coli and Salmonella typhimurium. Microbiol Rev. 1991 Dec;55(4):561–585. doi: 10.1128/mr.55.4.561-585.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Flegr J., Hrdý I. Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol (Praha) 1994;41(2):122–126. [PubMed] [Google Scholar]
  15. Flegr J., Zitková S., Kodym P., Frynta D. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology. 1996 Jul;113(Pt 1):49–54. doi: 10.1017/s0031182000066269. [DOI] [PubMed] [Google Scholar]
  16. Fox J. G. Non-human reservoirs of Helicobacter pylori. Aliment Pharmacol Ther. 1995;9 (Suppl 2):93–103. [PubMed] [Google Scholar]
  17. Gaston J. S. How does HLA-B27 confer susceptibility to inflammatory arthritis? Clin Exp Immunol. 1990 Oct;82(1):1–2. doi: 10.1111/j.1365-2249.1990.tb05394.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Goodacre J. A., Brownlie C. E., Ross D. A. Bacterial superantigens in autoimmune arthritis. Br J Rheumatol. 1994 May;33(5):413–419. doi: 10.1093/rheumatology/33.5.413. [DOI] [PubMed] [Google Scholar]
  19. Hayashi S., Chan C. C., Gazzinelli R., Roberge F. G. Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. J Immunol. 1996 Feb 15;156(4):1476–1481. [PubMed] [Google Scholar]
  20. Johnson H. M., Torres B. A., Soos J. M. Superantigens: structure and relevance to human disease. Proc Soc Exp Biol Med. 1996 Jun;212(2):99–109. doi: 10.3181/00379727-212-43996. [DOI] [PubMed] [Google Scholar]
  21. Kapasi K., Inman R. D. HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells. J Immunol. 1992 Jun 1;148(11):3554–3559. [PubMed] [Google Scholar]
  22. Kay R. A. The potential role of superantigens in inflammatory bowel disease. Clin Exp Immunol. 1995 Apr;100(1):4–6. doi: 10.1111/j.1365-2249.1995.tb03595.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Keusch G. T., Hamer D., Joe A., Kelley M., Griffiths J., Ward H. Cryptosporidia--who is at risk? Schweiz Med Wochenschr. 1995 May 6;125(18):899–908. [PubMed] [Google Scholar]
  24. Khalil S. S., Rashwan E. A. Tumour necrosis factor-alpha (TNF-alpha) in human toxoplasmosis. J Egypt Soc Parasitol. 1996 Apr;26(1):53–61. [PubMed] [Google Scholar]
  25. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev. 1995 Jul;8(3):411–426. doi: 10.1128/cmr.8.3.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kotb M. Infection and autoimmunity: a story of the host, the pathogen, and the copathogen. Clin Immunol Immunopathol. 1995 Jan;74(1):10–22. doi: 10.1006/clin.1995.1003. [DOI] [PubMed] [Google Scholar]
  27. Kuipers E. J., Uyterlinde A. M., Peña A. S., Roosendaal R., Pals G., Nelis G. F., Festen H. P., Meuwissen S. G. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995 Jun 17;345(8964):1525–1528. doi: 10.1016/s0140-6736(95)91084-0. [DOI] [PubMed] [Google Scholar]
  28. Lange W. R. Ciguatera fish poisoning. Am Fam Physician. 1994 Sep 1;50(3):579–584. [PubMed] [Google Scholar]
  29. Latman N. S., Walls R. Personality and stress: an exploratory comparison of rheumatoid arthritis and osteoarthritis. Arch Phys Med Rehabil. 1996 Aug;77(8):796–800. doi: 10.1016/s0003-9993(96)90259-2. [DOI] [PubMed] [Google Scholar]
  30. Leung D. Y., Meissner H. C., Fulton D. R., Murray D. L., Kotzin B. L., Schlievert P. M. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993 Dec 4;342(8884):1385–1388. doi: 10.1016/0140-6736(93)92752-f. [DOI] [PubMed] [Google Scholar]
  31. Lingwood C. A. Verotoxin-binding in human renal sections. Nephron. 1994;66(1):21–28. doi: 10.1159/000187761. [DOI] [PubMed] [Google Scholar]
  32. Liu Y., van Kruiningen H. J., West A. B., Cartun R. W., Cortot A., Colombel J. F. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology. 1995 May;108(5):1396–1404. doi: 10.1016/0016-5085(95)90687-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Luo G., Seetharamaiah G. S., Niesel D. W., Zhang H., Peterson J. W., Prabhakar B. S., Klimpel G. R. Purification and characterization of Yersinia enterocolitica envelope proteins which induce antibodies that react with human thyrotropin receptor. J Immunol. 1994 Mar 1;152(5):2555–2561. [PubMed] [Google Scholar]
  34. McGuigan L. E., Prendergast J. K., Geczy A. F., Edmonds J. P., Bashir H. V. Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis. Ann Rheum Dis. 1986 Jul;45(7):566–571. doi: 10.1136/ard.45.7.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Millar D., Ford J., Sanderson J., Withey S., Tizard M., Doran T., Hermon-Taylor J. IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales. Appl Environ Microbiol. 1996 Sep;62(9):3446–3452. doi: 10.1128/aem.62.9.3446-3452.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Miller F. W. Genetics of autoimmune diseases. Exp Clin Immunogenet. 1995;12(3):182–190. doi: 10.1159/000424870. [DOI] [PubMed] [Google Scholar]
  37. Moyer L., Warwick M., Mahoney F. J. Prevention of hepatitis A virus infection. Am Fam Physician. 1996 Jul;54(1):107–114. [PubMed] [Google Scholar]
  38. Neal G. E. Genetic implications in the metabolism and toxicity of mycotoxins. Toxicol Lett. 1995 Dec;82-83:861–867. doi: 10.1016/0378-4274(95)03600-8. [DOI] [PubMed] [Google Scholar]
  39. Olle P., Bessieres M. H., Malecaze F., Seguela J. P. The evolution of ocular toxoplasmosis in anti-interferon gamma treated mice. Curr Eye Res. 1996 Jul;15(7):701–707. doi: 10.3109/02713689609003451. [DOI] [PubMed] [Google Scholar]
  40. Oomes P. G., Jacobs B. C., Hazenberg M. P., Bänffer J. R., van der Meché F. G. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann Neurol. 1995 Aug;38(2):170–175. doi: 10.1002/ana.410380208. [DOI] [PubMed] [Google Scholar]
  41. Owen R. J. Bacteriology of Helicobacter pylori. Baillieres Clin Gastroenterol. 1995 Sep;9(3):415–446. doi: 10.1016/0950-3528(95)90041-1. [DOI] [PubMed] [Google Scholar]
  42. Peterson M. C. Clinical aspects of Campylobacter jejuni infections in adults. West J Med. 1994 Aug;161(2):148–152. [PMC free article] [PubMed] [Google Scholar]
  43. Pudymaitis A., Armstrong G., Lingwood C. A. Verotoxin-resistant cell clones are deficient in the glycolipid globotriosylceramide: differential basis of phenotype. Arch Biochem Biophys. 1991 May 1;286(2):448–452. doi: 10.1016/0003-9861(91)90064-p. [DOI] [PubMed] [Google Scholar]
  44. Rahaman S. M., Chira P., Koff R. S. Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am J Gastroenterol. 1994 Jan;89(1):106–108. [PubMed] [Google Scholar]
  45. Robens J. F., Richard J. L. Aflatoxins in animal and human health. Rev Environ Contam Toxicol. 1992;127:69–94. doi: 10.1007/978-1-4613-9751-9_3. [DOI] [PubMed] [Google Scholar]
  46. Seppel T., Rose F., Schlaghecke R. Chronic intestinal giardiasis with isolated levothyroxine malabsorption as reason for severe hypothyroidism--implications for localization of thyroid hormone absorption in the gut. Exp Clin Endocrinol Diabetes. 1996;104(2):180–182. doi: 10.1055/s-0029-1211442. [DOI] [PubMed] [Google Scholar]
  47. Shoenfeld Y., George J., Peter J. B. Guillain-Barré as an autoimmune disease. Int Arch Allergy Immunol. 1996 Apr;109(4):318–326. doi: 10.1159/000237258. [DOI] [PubMed] [Google Scholar]
  48. Sieper J., Braun J. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum. 1995 Nov;38(11):1547–1554. doi: 10.1002/art.1780381105. [DOI] [PubMed] [Google Scholar]
  49. Sipponen P., Kekki M., Seppälä K., Siurala M. The relationships between chronic gastritis and gastric acid secretion. Aliment Pharmacol Ther. 1996 Apr;10 (Suppl 1):103–118. doi: 10.1046/j.1365-2036.1996.22164011.x. [DOI] [PubMed] [Google Scholar]
  50. Strittmatter C., Lang W., Wiestler O. D., Kleihues P. The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases. Acta Neuropathol. 1992;83(5):475–481. doi: 10.1007/BF00310023. [DOI] [PubMed] [Google Scholar]
  51. Swift A. E., Swift T. R. Ciguatera. J Toxicol Clin Toxicol. 1993;31(1):1–29. doi: 10.3109/15563659309000371. [DOI] [PubMed] [Google Scholar]
  52. Tarr P. I. Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis. 1995 Jan;20(1):1–10. doi: 10.1093/clinids/20.1.1. [DOI] [PubMed] [Google Scholar]
  53. Tesh V. L., O'Brien A. D. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol Microbiol. 1991 Aug;5(8):1817–1822. doi: 10.1111/j.1365-2958.1991.tb00805.x. [DOI] [PubMed] [Google Scholar]
  54. Wolf M. W., Misaki T., Bech K., Tvede M., Silva J. E., Ingbar S. H. Immunoglobulins of patients recovering from Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes. Thyroid. 1991 Winter;1(4):315–320. doi: 10.1089/thy.1991.1.315. [DOI] [PubMed] [Google Scholar]
  55. Wolfe M. S. Giardiasis. Clin Microbiol Rev. 1992 Jan;5(1):93–100. doi: 10.1128/cmr.5.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. von Herrath M. G., Oldstone M. B. Virus-induced autoimmune disease. Curr Opin Immunol. 1996 Dec;8(6):878–885. doi: 10.1016/S0952-7915(96)80019-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES